Wednesday, June 18, 2008 - 9:50 AM
Room 4 (McKimmon Conference Center)
432

Aggregation in High Concentration Formulations of Recombinant Human Interleukin-1 Receptor Antagonist: Colloidal Stability Effects

Theodore W. Randolph1, John Carpenter2, and John R. Alford1. (1) University of Colorado, Boulder, Boulder, CO, (2) University of Colorado Health Sciences Center, Denver, CO

At high protein concentrations (i.e. 50-100 mg/mL) and 37°C, low solution ionic strength accelerates aggregation of recombinant human interleukin-1 receptor antagonist (rhIL-1ra). To explain these observations, we have determined protein assembly state behavior using analytical ultracentrifugation, and combined these results with measured free energies of unfolding as a function of ionic strength, as well as second osmotic virial coefficients determined by light scattering. In addition, a population balance model was applied to aggregate growth kinetics to determine aggregate nucleation and growth rates. Activity coefficient of rhIL-1ra estimated from aggregation rates is 50 % higher at 100 mg/mL protein concentration than at 50 mg/mL, in close agreement with predictions from a hard-sphere model for activity coefficients.